Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma
Changhoon Yoo, Jihoon Kang, Ho Yeong Lim, Jee Hyun Kim, Myung-Ah Lee, Kyung-Hun Lee, Tae-You Kim, Baek-Yeol Ryoo
Cancer Res Treat. 2019;51(2):510-518.   Published online 2018 Jun 13     DOI: https://doi.org/10.4143/crt.2018.226
Citations to this article as recorded by Crossref logo
An update on investigational therapies that target STAT3 for the treatment of cancer
Matteo Santoni, Francesca Miccini, Alessia Cimadamore, Francesco Piva, Francesco Massari, Liang Cheng, Antonio Lopez-Beltran, Rodolfo Montironi, Nicola Battelli
Expert Opinion on Investigational Drugs.2021; 30(3): 245.     CrossRef
Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors
Dingding Gao, Nan Jin, Yixian Fu, Yueyue Zhu, Yujie Wang, Ting Wang, Yuehong Chen, Mingming Zhang, Qiang Xiao, Min Huang, Yingxia Li
European Journal of Medicinal Chemistry.2021; 216: 113333.     CrossRef
NAFLD-Associated HCC: Progress and Opportunities
Daniel Geh, Quentin M Anstee, Helen L Reeves
Journal of Hepatocellular Carcinoma.2021; Volume 8: 223.     CrossRef
The therapeutic potential of mitochondrial toxins
Manabu Kawada, Masahide Amemiya, Junjiro Yoshida, Tomokazu Ohishi
The Journal of Antibiotics.2021; 74(10): 696.     CrossRef
Advances of Targeted Therapy for Hepatocellular Carcinoma
Mengke Niu, Ming Yi, Ning Li, Kongju Wu, Kongming Wu
Frontiers in Oncology.2021;[Epub]     CrossRef
Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma
Shusil K. Pandit, Giada Sandrini, Jessica Merulla, Valentina Nobili, Xin Wang, Alessia Zangari, Andrea Rinaldi, Dheeraj Shinde, Giuseppina M. Carbone, Carlo V. Catapano
Cancers.2021; 13(23): 6029.     CrossRef
Phosphotyrosine isosteres: past, present and future
Robert A. Cerulli, Joshua A. Kritzer
Organic & Biomolecular Chemistry.2020; 18(4): 583.     CrossRef
Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis
Alessia Virzì, Armando Andres Roca Suarez, Thomas F. Baumert, Joachim Lupberger
Cold Spring Harbor Perspectives in Medicine.2020; 10(1): a037366.     CrossRef
Quinazoline Ligands Induce Cancer Cell Death through Selective STAT3 Inhibition and G-Quadruplex Stabilization
Jan Jamroskovic, Mara Doimo, Karam Chand, Ikenna Obi, Rajendra Kumar, Kristoffer Brännström, Mattias Hedenström, Rabindra Nath Das, Almaz Akhunzianov, Marco Deiana, Kazutoshi Kasho, Sebastian Sulis Sato, Parham L. Pourbozorgi, James E. Mason, Paolo Medini
Journal of the American Chemical Society.2020; 142(6): 2876.     CrossRef
JAK/STAT signaling in hepatocellular carcinoma
Justin Jit Hin Tang, Dexter Kai Hao Thng, Jhin Jieh Lim, Tan Boon Toh
Hepatic Oncology.2020; 7(1): HEP18.     CrossRef
Targeting apoptosis in cancer therapy
Benedito A. Carneiro, Wafik S. El-Deiry
Nature Reviews Clinical Oncology.2020; 17(7): 395.     CrossRef
Targeting acute myeloid leukemia stem cells: Current therapies in development and potential strategies with new dimensions
Yuxin Tan, Qiuji Wu, Fuling Zhou
Critical Reviews in Oncology/Hematology.2020; 152: 102993.     CrossRef
Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies
Ethan L. Morgan, Andrew Macdonald
Viruses.2020; 12(9): 977.     CrossRef
STAT3 inhibition protects against neuroinflammation and BACE1 upregulation induced by systemic inflammation
Périne Millot, Carine San, Evangeline Bennana, Baptiste Porte, Nicolas Vignal, Jacques Hugon, Claire Paquet, Benoit Hosten, François Mouton-Liger
Immunology Letters.2020; 228: 129.     CrossRef
STAT3 Inhibitor OPB-51602 Is Cytotoxic to Tumor Cells Through Inhibition of Complex I and ROS Induction
Lara Brambilla, Tanaya Lahiri, Michael Cammer, David E. Levy
iScience.2020; 23(12): 101822.     CrossRef
Systemic Therapy for Hepatocellular Carcinoma: Advances and Hopes
Chen-Hao Zhang, Ming Li, You-Pei Lin, Qiang Gao
Current Gene Therapy.2020; 20(2): 84.     CrossRef
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Jiang-Jiang Qin, Li Yan, Jia Zhang, Wei-Dong Zhang
Journal of Experimental & Clinical Cancer Research.2019;[Epub]     CrossRef
Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma
Kazuki Takakura, Tsunekazu Oikawa, Masanori Nakano, Chisato Saeki, Yuichi Torisu, Mikio Kajihara, Masayuki Saruta
Frontiers in Oncology.2019;[Epub]     CrossRef
Direct Targeting Options for STAT3 and STAT5 in Cancer
Anna Orlova, Christina Wagner, Elvin D. de Araujo, Dávid Bajusz, Heidi A. Neubauer, Marco Herling, Patrick T. Gunning, György M. Keserű, Richard Moriggl
Cancers.2019; 11(12): 1930.     CrossRef